// App-Quantinova.ai

10L : Aiming for Remission in Rheumatoid Arthritis: Clinical and Radiographic Outcomes from a Randomized Controlled Strategy Trial Investigating the Added Value of Ultrasonography in a Treat-to-Target Regimen

Researchers

Presenter

  • Espen A. Haavardsholm

Principal Investigators

  • Anna-Birgitte Aga

  • Inge C Olsen

  • Hilde Stray

  • Anne Noraas Bendvold

  • Inger Johanne Widding Hansen

  • Gunnstein Bakl

  • Lena B. Nordberg

  • Hilde B. Hammer

  • Till Uhlig

  • Hallvard Fremstad

  • Tor Magne Madl

  • Ase S. Lexberg

  • Hilde Haukel

  • Erik Rodev

  • Christian Hoili

Medical Centers

  • Department of Oncology, Haukeland University Hospital, Bergen, Norway

  • Diakonhjemmet Hospital, Oslo, Norway

  • Dept. of Rheumatology, Hospital Ostfold HF, Moss, Norway

  • Dept. of Rheumatology, St. Olavs Hospital, Trondheim, Norway

  • Dept. of Rheumatology, University Hospital Northern Norway, Tromso, Norway

  • The Rheumatology Clinic Dovland/Bendvold, Kristiansand, Norway

  • Department of Medical Statistics, Leiden University Medical Center, Leiden, Netherlands

  • Dept. of Rheumatology, Sorlandet Hospital, Kristiansand, Norway

  • Diakonhjemmet Hospital, Oslo, Norway

Locations

  • Norway

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Circulating tumor cells

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • randomized

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved